Hints and tips:
...Christopher Cassidy, vice-president at Schott North America, blamed the delays on the ramp up in production of Covid-19 vaccine vials. It expects to make 2bn this year....
...But “hateful” is too strong a word, especially for those Americans who remember the late Cincinnati Reds baseball owner Marge Schott, who was censured in the 1990s for saying Adolf Hitler “was good in the...
...And quite often they’re not the people who will go to a Verdi opera,” says Sally Groves, director of Schott Music, which published Stoned Prince and Stewart Wallace’s Harvey Milk....
...At men’s site Mr Porter, there’s Schott’s vintage oiled leather Perfecto (£1,140) and a cuffed biker/bomber hybrid (£705) from McQ by Alexander McQueen....
...And British designer Christopher Raeburn launched his collaborative line – Moncler R – this winter, with zigzag quilt jackets and parkas (priced from £1,245)....
...Chris Schott, analyst at Bank of America, said Plavix, which Bristol sells in partnership with French drugmaker Sanofi-Aventis as the only anti-platelet drug on the market, “would benefit from a weakened...
...Chris Schott, analyst at Bank of America, said: “Merck’s focus on new mechanisms of action [for novel drugs] positions the company well for the current difficult FDA environment.”...
...Chris Schott, analyst at Bank of America, said: “We view the news today as refuelling takeout speculation…” Sanofi is understood to have looked at acquiring Bristol, on the back of its co-operation deal...
...Chris Schott, analyst at Bank of America, said: “The earnings beat was primarily due to stronger-than-expected revenue, with expenses in line with expectations.”...
...Chris Schott, analyst at Bank of America, estimated that Bristol could lose 80 per cent of its second-half Plavix sales this year....
...Chris Schott, analyst at Bank of America, said: “We believe, given Mr Cornelius’s background, that the market will continue to raise the possibility of Bristol as a takeover candidate.”...
...Chris Schott, analyst at Bank of America, said: “Lipitor will likely remain the focus of the Pfizer story over the next several quarters ahead of Zocor’s June patent expiration.”...
International Edition